Discussion about this post

User's avatar
one patient’s pen's avatar

This is a really important distinction.. thanks for breaking it down!

Moro Balakrishnan's avatar

And like in the case of hypertension limits and lipid standards, the limits are being continuously revised over a long time only to sustain the drug industry. I am sure diabetes is also one. Like the new GLP-1 drugs. Repurposing them for diabetes, is an icing on the cake for the drug industry for these new class of drugs. They will instantly double the profit margins on these expensive drugs and as they last, it is a windfall for the industry. Keep labelling most people as diabetic.

5 more comments...

No posts

Ready for more?